Tenofovir Disoproxil Fumarate: A Review of its Use in the Management of HIV infection

Author： Lyseng-Williamson Katherine A.   Reynolds Neil A.   Plosker Greg L.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.3, 2005-01, pp. : 413-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®): A Review of its Use in the Management of HIV Infection

By Deeks Emma D.   Perry Caroline M.  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2315-2338

Adis International

Access to resources Recommend Favorite

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Guide to Its Use in HIV-1 Infection

By Lyseng-Williamson Katherine A.   Scott Lesley J.  

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 715-722

Adis International

Access to resources Recommend Favorite

Emtricitabine/Tenofovir Disoproxil Fumarate: In Combination with a Protease Inhibitor in HIV-1 Infection

By Perry Caroline M.  

Drugs, Vol. 69, Iss. 7, 2009-05 ,pp. : 843-857

Adis International

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate: durable efficacy in heavily pretreated HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients

By Gazzard Brian G  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 793-802

Informa Healthcare

Access to resources Recommend Favorite